NEW YORK, Jan. 3, 2017 /PRNewswire/ -- A teething tablets lawsuit has been filed on behalf of consumers who purchased homeopathic remedies that were recently the subject of a U.S. Food & Drug Administration (FDA) safety warning. The class action complaint, which is currently pending in the U.S. District Court, Southern District of New York, accuses Hyland's Inc., and other defendants of marketing useless and unsafe teething pills and gels. While the FDA's alert resulted in the voluntary withdrawal of the products from store shelves, plaintiffs say they were never offered refunds for their purchases. (Case No. 7:16-cv-08687-KMK)
"Our Firm has heard from a number of consumers who believe their children may have been harmed by homeopathic teething remedies, so this filing is not surprising. Our attorneys are investigating potential legal claims involving injuries that may be associated with these products, including teething tablets-related seizures and deaths," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering free, no-obligation legal reviews to families who are interested in pursuing a teething tablets lawsuit on behalf of an injured child.
FDA Teething Tablets Warnings
In September 2016, the FDA warned parents and caregivers not to use homeopathic tablets or gels to treat teething pain in infants and children. It was subsequently revealed that these products, which include medications marketed by Hyland's, Baby Orajel Naturals and others, could be linked to more than 400 adverse events reported to the agency since 2010, including 10 infant deaths. The FDA also noted that the health benefits purportedly associated with homeopathic teething remedies remain unproven. Consumers who have purchased these products should seek medical attention for their child if they experience any of the following reactions after use:
- Difficulty breathing
- Excessive sleepiness
- Muscle weakness
- Skin flushing
- Difficulty urinating
The FDA warning prompted CVS to remove all homeopathic teething tablets and gels from its store shelves. Hyland's subsequently announced that it would stop marketing its teething remedies in the U.S. In 2010, the same company announced a teething tablets recall, after its products were linked to a number of adverse events typical of belladonna toxicity. Testing suggested that the pills contained inconsistent amounts of this ingredient, which can be poisonous if ingested in large amounts.
On November 24, 2016, Raritan Pharmaceuticals announced a recall of its homeopathic teething tablets and ear pain liquids after tests suggested they might also contain varying amounts of belladonna. To date, the Raritan medications have not been linked to any reported injuries.
Children who suffered complications allegedly related to homeopathic teething medications may be entitled to compensation for injury-related damages. To contact a teething tablets lawyer today, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation review of your potential case.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2017 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
SOURCE Bernstein Liebhard LLP